-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KofnMf7eiMYzn5wImuJkr0G+XFBD7XlcNt6OQ1AXuIAXQ5Pv4OtJo6SO++N7+RKU HOSTb/x/0/OKFpXALvI5Sw== 0001231977-04-000036.txt : 20041109 0001231977-04-000036.hdr.sgml : 20041109 20041109120058 ACCESSION NUMBER: 0001231977-04-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041108 FILED AS OF DATE: 20041109 DATE AS OF CHANGE: 20041109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 041128124 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2004-11-08 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 Chief Executive Officer Common Stock, par value $.0001 2004-11-08 4 M 0 11952 2.375 A 261612 D Common Stock, par value $.0001 2004-11-08 4 M 0 1501 2.375 A 263113 D Common Stock, par value $.0001 2004-11-08 4 S 0 7801 19.94 D 255312 D Option to Purchase Common Stock, par value $.0001 2.375 2004-11-08 4 M 0 11952 0 D 1999-02-10 2005-02-10 Common Stock, par value $.0001 11952 0 D Option to Purchase Common Stock, par value $.0001 2.375 2004-11-08 4 M 0 1501 0 D 1999-05-01 2005-05-01 Common Stock, par value $.0001 1501 67708 D The sales reported by this Form 4 are made pursuant to the terms of a Sales Plan designed to meet the requirements of Rule 10b5-1 (c) (1) of the Securities Exchange Act. Dr. Leonard Bell 2004-11-09 -----END PRIVACY-ENHANCED MESSAGE-----